364 Zero Itch in Eyes Treated With Olopatadine Hydrochloride Ophthalmic Solution, 0.2% in Bilateral Conjunctival Allergen Challenge Studies

World Allergy Organization Journal ◽

10.1097/01.wox.0000412127.79639.64 ◽

2012 ◽

Vol 5 ◽

pp. S116-S117

Author(s):

Michael S. Blaiss ◽

Maria Tort

Keyword(s):

Allergen Challenge ◽

Ophthalmic Solution ◽

Conjunctival Allergen Challenge ◽

Olopatadine Hydrochloride

Download Full-text

Comparison of the clinical efficacy and comfort of olopatadine hydrochloride 0.1% ophthalmic solution and nedocromil sodium 2% ophthalmic solution in the human conjunctival allergen challenge model

Clinical Therapeutics ◽

10.1016/s0149-2918(00)83044-1 ◽

2000 ◽

Vol 22 (12) ◽

pp. 1462-1472 ◽

Author(s):

Salim Butrus ◽

Jack V. Greiner ◽

Marino Discepola ◽

Ira Finegold

Keyword(s):

Clinical Efficacy ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Nedocromil Sodium ◽

Conjunctival Allergen Challenge ◽

Olopatadine Hydrochloride

Download Full-text

A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model

Clinical Therapeutics ◽

10.1016/j.clinthera.2005.04.011 ◽

2005 ◽

Vol 27 (5) ◽

pp. 568-577 ◽

Author(s):

Jack V. Greiner ◽

Ira J. Udell

Keyword(s):

Clinical Efficacy ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Pheniramine Maleate ◽

Conjunctival Allergen Challenge ◽

Olopatadine Hydrochloride

Download Full-text

Evaluation of Comfort Using Olopatadine Hydrochloride 0.1% Ophthalmic Solution in the Treatment of Allergic Conjunctivitis in Contact Lens Wearers Compared to Placebo Using the Conjunctival Allergen-Challenge Model

Eye & Contact Lens Science & Clinical Practice ◽

10.1097/01.icl.0000063576.32087.f7 ◽

2003 ◽

Vol 29 (2) ◽

pp. 113-116 ◽

Author(s):

Miguel Brodsky ◽

William E. Berger ◽

Salim Butrus ◽

Arthur B. Epstein ◽

Murat Irkec

Keyword(s):

Contact Lens ◽

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Conjunctival Allergen Challenge ◽

Olopatadine Hydrochloride

Download Full-text

Phase 3 Randomized Double-Masked Study of Efficacy and Safety of Once-Daily 0.77% Olopatadine Hydrochloride Ophthalmic Solution in Subjects With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge Model

Cornea ◽

10.1097/ico.0000000000000562 ◽

2015 ◽

Vol 34 (10) ◽

pp. 1245-1251 ◽

Author(s):

Eugene McLaurin ◽

Abhijit Narvekar ◽

Paul Gomes ◽

Adeniyi Adewale ◽

Gail Torkildsen

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Efficacy And Safety ◽

Phase 3 ◽

Conjunctival Allergen Challenge ◽

Olopatadine Hydrochloride

Download Full-text

Comparison of the clinical efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and loteprednol etabonate 0.2% ophthalmic suspension in the conjunctival allergen challenge model

Clinical Therapeutics ◽

10.1016/s0149-2918(02)80007-8 ◽

2002 ◽

Vol 24 (6) ◽

pp. 918-929 ◽

Author(s):

Gregg J. Berdy ◽

Juan O. Stoppel ◽

Arthur B. Epstein

Keyword(s):

Clinical Efficacy ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Loteprednol Etabonate ◽

Conjunctival Allergen Challenge ◽

Olopatadine Hydrochloride ◽

Ophthalmic Suspension

Download Full-text

An Evaluation of Onset and Duration of Action of Patanol® (Olopatadine Hydrochloride Ophthalmic Solution 0.1%) Compared to Claritin® (Loratadine 10 mg) Tablets in Acute Allergic Conjunctivitis in the Conjunctival Allergen Challenge Model

Acta Ophthalmologica Scandinavica ◽

10.1034/j.1600-0420.2000.078s230060.x ◽

2000 ◽

Vol 78 ◽

pp. 60-63 ◽

Author(s):

Mark B. Abelson ◽

Donna L. Welch

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Duration Of Action ◽

Conjunctival Allergen Challenge ◽

Olopatadine Hydrochloride

Download Full-text

Efficacy of Ketotifen Fumarate 0.025% Ophthalmic Solution Compared With Placebo in the Conjunctival Allergen Challenge Model

Archives of Ophthalmology ◽

10.1001/archopht.121.5.626 ◽

2003 ◽

Vol 121 (5) ◽

pp. 626 ◽

Author(s):

Mark B. Abelson

Keyword(s):

Allergen Challenge ◽

Ophthalmic Solution ◽

Ketotifen Fumarate ◽

Conjunctival Allergen Challenge

Download Full-text

Emedastine ophthalmic solution 0.05% versus levocabastine ophthalmic suspension 0.05% in the treatment of allergic conjunctivitis using the conjunctival allergen challenge model

American Journal of Ophthalmology ◽

10.1016/s0002-9394(00)00689-9 ◽

2000 ◽

Vol 130 (6) ◽

pp. 717-723 ◽

Author(s):

Peter A Netland ◽

Charles Leahy ◽

Kathleen L Krenzer

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Conjunctival Allergen Challenge ◽

Ophthalmic Suspension

Download Full-text

Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial

Clinical Therapeutics ◽

10.1016/s0149-2918(03)80199-6 ◽

2003 ◽

Vol 25 (7) ◽

pp. 1975-1987 ◽

Author(s):

H.Jerome Crampton

Keyword(s):

Controlled Trial ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Signs And Symptoms ◽

Allergic Rhinoconjunctivitis ◽

Ketotifen Fumarate ◽

Conjunctival Allergen Challenge

Download Full-text

Bioequivalence of two formulations of ketotifen fumarate ophthalmic solution: A single-center, randomized, double-masked conjunctival allergen challenge investigation in allergic conjunctivitis

Clinical Therapeutics ◽

10.1016/s0149-2918(08)80051-3 ◽

2008 ◽

Vol 30 (7) ◽

pp. 1272-1282 ◽

Author(s):

Gail L. Torkildsen ◽

Mark B. Abelson ◽

Paul J. Gomes

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Single Center ◽

Ketotifen Fumarate ◽

Conjunctival Allergen Challenge

Download Full-text